Rafferty Asset Management, LLC Neurocrine Biosciences Inc Transaction History
Rafferty Asset Management, LLC
- $22.9 Billion
- Q1 2025
A detailed history of Rafferty Asset Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 100,807 shares of NBIX stock, worth $13.8 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
100,807
Previous 107,011
5.8%
Holding current value
$13.8 Million
Previous $14.6 Million
23.67%
% of portfolio
0.05%
Previous 0.05%
Shares
25 transactions
Others Institutions Holding NBIX
# of Institutions
654Shares Held
96.6MCall Options Held
800KPut Options Held
565K-
Black Rock Inc. New York, NY14.2MShares$1.94 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.36 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$757 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$665 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$365 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...